Arterial hypertension in pregnancy and placental vascularization

Margarita S. Simonova; A. G Goryunova; A. V Murashko; S. A Timofeev

doi:10.18821/2313-8726-2017-4-1-15-19

V.F.Snegirev Archives of Obstetrics and Gynecology ›› 2017, Vol. 4 ›› Issue (1) : 15 -19. DOI: 10.18821/2313-8726-2017-4-1-15-19

Original study articles

research-article

Arterial hypertension in pregnancy and placental vascularization

Author information +

History +

PDF

Abstract

There are considered modern data on etiology, pathogenesis, the course of pregnancy, methods of the diagnosis of arterial hypertension in pregnancy. There are presented data about the morphological changes in the placenta, the role of growthfactors and their receptors, as well as modern views on the problem ofplacental insufficiency as the main cause of hypertension in pregnancy.

Keywords

hypertension / pre-eclampsia / placental insufficiency / placental growth factor

Cite this article

Download citation ▾

Margarita S. Simonova, A. G Goryunova, A. V Murashko, S. A Timofeev. Arterial hypertension in pregnancy and placental vascularization. V.F.Snegirev Archives of Obstetrics and Gynecology, 2017, 4(1): 15-19 DOI:10.18821/2313-8726-2017-4-1-15-19

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Цибулькин Н.А., Маянская С.Д., Абдрахманова А.И. Артериальная гипертензия при беременности. Практическая медицина. 2010; 5 (44): 32-5.

[2]	Gifford R.W., August P.A., Cunningham G. Working Group Report on High Blood Pressure in Pregnancy. Am. J. Obstet. Gynecol. 2000;183: 181-92.

[3]	WHO International Collaborative Study of Hypertensive Disorders of Pregnancy. Geographic variation in the incidence of hypertension in pregnancy. Am. J. Obstet. Gynecol. 1988; 158: 80-3.

[4]	Серов В.Н., Стрижаков А.Н., Маркин С.А. Руководство по практическому акушерству. М.: МИА; 1997.

[5]	Серов В.Н., Стрижаков А.Н., Маркин С.А. Практическое акушерство. М.: Медицина; 1989.

[6]	Верткин А.Л., Ткачева О.Н., Мурашко Л.Е., Мишина И.Е., Тумбаев И.В. Артериальная гипертония беременных: диагностика, тактика ведения и подходы к лечению. Лечащий врач. 2006; (3): 18-22.

[7]	English F.A., Kenny L.C., McCarthy F.P. Risk factors and effective management of preeclampsia. Integr. Blood Press. Control. 2015; 8: 7-12. Doi: 10.2147/IBPC.S50641. eCollection 2015. Review.

[8]	Dietl J. The pathogenesis of pre-eclampsia: new aspects. J. Perinat. Med. 2000; 28: 464-71.

[9]	Oudejans C.B.M., Tjoa M.L., Westerman B.A., Mulders M.A.M., van Wijk I.J., van Vugt J.M.G. Circulating trophoblast in maternal blood. Prenat. Diagn. 2003; 23: 111-6.

[10]	Fisher S.J. The placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsia. Reprod. Biol. Endocrinol. 2004; 2: 53-6.

[11]	Bdolah Y., Karumanchi S.A., Sachs B.P. Recent advances in understanding of preeclampsia. Croat. Med. J. 2005; 46: 728-36.

[12]	Айламазян Э.К., Мозговая Е.В. Гестоз: теория и практика. М.: МЕДпресс-информ; 2008: 72-6.

[13]	Pijnenborg R., Anthony J., Davey D.A., Rees A., Tiltman A., Vercruysse E., Assche A.V. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br. J. Obstet. Gynaecol. 1991; 98: 648-55.

[14]	Шилин Д.Е., Адамян Л.В., Шилин Д.А. и др. Новое в профилактике преэклампсии. В кн.: Новые технологии в диагностике и лечении гинекологических заболеваний. М.; 2009: 125-6.

[15]	Серов В.Н., Гаспаров А.С., Кулаков В.И. Акушерство. М.: МИА; 2009: 320-44.

[16]	Адашева Т.В., Демичева О.Ю. Артериальная гипертония беременных: патогенез, классификация, подходы к лечению. Лечащий врач. 2004; (2): 43-7.

[17]	Brosens I., Robcrtson W.B., Dixon H.G. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet. Gynecol. Annu. 1972; 1: 177-91.

[18]	Gerretsen G., Huisjes H.J., Hardonk M.J., Elema J.D. Trophoblast alterations in the placental bed in relation to physiological changes in spiral arteries. Br. J. Obstet. Gynaecol. 1983; 90: 34-9.

[19]	Lam C., Lim K.-H., Karumanchi S.A. Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertens. Res. 2005; 46: 1077-85.

[20]	Levine R., Maynard S., Qian C., Lim K., England H. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 2004; 350: 672-83.

[21]	Wang A., Rana S., Karumanchi S.A. Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology. 2009; 24: 147-58.

[22]	Poon L.C., Nicolaides K.H. Early prediction of preeclampsia. Review. Obstet. Gynecol. Int. 2014; Article ID 297397; http://dx.doi.org/10.1155/2014/297397.

[23]	Shibata E., Rajakumar A., Roberts R.W. et al. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J. Clin. Endocrinol. Metab. 2005; 90: 4895-903.

[24]	De Vivo A., Baviera G., Giorano D. et al. Endoglin, PlGF and SFLT-1 as markers for predicting preeclampsia. Acta Obstet. Gynecol. Scand. 2008; 87: 837-42.

[25]	Chappel L.C., Duckworth S., Seed P.T. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study. Circulation. 2013; 128: 2121-31.

[26]	Lowry F. New Test Identifies Preeclampsia Requiring Delivery. 2013. Medscape, November 04. (www.medscape.com/viewarticle/813764).

[27]	Verlohren S., Galindo A., Schlembach D., Zeisler H., Herraiz J. An automated method for the determination of the sFIT-1/PIGF ratio in the assessment of preeclampsia. Am. J. Obstet. Gynecol. 2010; 202: 161-73.

[28]	Pantham P., Askelund K.J., Chamley L.W. Trophoblast deportation, part II: A review of the maternal consequences of trophoblast deportation. Placenta. 2011; 32: 724-31.